WHO ICTRP trial
Oral Versus Intravenous Dexamethasone in Community-acquired pneumonia study
NL-OMON36192 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON36192 |
|---|---|
| Public title | Oral Versus Intravenous Dexamethasone in Community-acquired pneumonia study |
| Scientific title | Oral Versus Intravenous Dexamethasone in Community-acquired pneumonia study - OVID study |
| Primary sponsor | Sint Antonius Ziekenhuis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Countries | Netherlands |
| Conditions | lower respiratory tract infection Pneumonia;10024970;lower respiratory tract infection;Pneumonia |
| Interventions | Subjects will be assigned to 6 mg dexamethasone starting dose administered PO, followed by 3 times 6 mg dexamethasone PO once daily or 5,26 mg dexamethasonedisodiumphosphate (= 4 mg dexamethasone) starting dose administered IV, followed by… |
| Registration date | Jun 30, 2011 |
| Target size | 30 |
| Secondary IDs | 2011-002346-12;NL36999.100.11;volgt na goedkeuring |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: